Top

Cancer Immunology, Immunotherapy

Published in:

01-12-2017 | Original Article

Atopy and prostate cancer: Is there a link between circulating levels of IgE and PSA in humans?

Authors: Mieke Van Hemelrijck, Sophia N. Karagiannis, Sabine Rohrmann

Published in: Cancer Immunology, Immunotherapy | Issue 12/2017

Abstract

Background

Atopy has been investigated as a potential risk factor for prostate cancer. IgE antibodies may be major players in protective responses against tumours, through engendering antigen presentation and enhancing adaptive immune responses targeted towards a specific allergen, but potentially also against tumour-associated antigens such as prostate-specific antigen (PSA). We therefore cross-sectionally investigated associations between circulating levels of PSA and IgE in the National Health and Nutrition Examination Survey 2005–2006.

Methods

We focused on all men aged 40+ years with measurements for PSA and IgE, and no previous diagnosis of prostate cancer (n = 1312). We estimated the association between total and specific IgE concentration and levels of PSA with logistic regression models, adjusted for age, ethnicity/race, education, smoking status, body mass index (BMI), physical activity status, and history of asthma.

Results

Both total IgE and the sum of specific IgE were inversely associated with the risk of having PSA levels ≥10 ng/mL, though most findings were not statistically significant. The odds ratios for the second and third tertile of total IgE as compared to the first were 0.21 (95% CI 0.06–0.72) and 0.42 (0.08–2.31). The odds ratio for sum of abnormal specific IgE measurements was 0.77 (0.44–1.34).

Conclusion

Despite statistical insignificance, the observed trend warrants further research given the increasing evidence of the role of atopy and IgE antibodies in protective responses against tumours. A lifecourse approach of measuring IgE, specific subtypes, and other markers of the humoral immune system (i.e. IgG) could shed more light on its potential anti-cancer characteristics.

Skaaby T, Nystrup Husemoen LL, Roswall N, Thuesen BH, Linneberg A (2014) Atopy and development of cancer: a population-based prospective study. J Allergy Clin Immunol Pract 2(6):779–785CrossRefPubMed

Talbot-Smith A, Fritschi L, Divitini ML, Mallon DF, Knuiman MW (2003) Allergy, atopy, and cancer: a prospective study of the 1981 Busselton cohort. Am J Epidemiol 157(7):606–612CrossRefPubMed

Wang H, Rothenbacher D, Low M, Stegmaier C, Brenner H, Diepgen TL (2006) Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int J Cancer 119(3):695–701CrossRefPubMed

Vojtechova P, Martin RM (2009) The association of atopic diseases with breast, prostate, and colorectal cancers: a meta-analysis. Cancer Causes Control 20(7):1091–1105CrossRefPubMed

Su YL, Chou CL, Rau KM, Lee CT (2015) Asthma and risk of prostate cancer: a population-based case-cohort study in Taiwan. Medicine (Baltimore). 94(36):e1371CrossRefPubMedPubMedCentral

Weiss D, El-Zein M, Rousseau MC, Richard H, Karakiewicz PI, Parent ME (2014) Asthma, allergy and the risk of prostate cancer: results from the Montreal PROtEuS study. Cancer Epidemiol 38(6):695–699CrossRefPubMed

Severi G, Baglietto L, Muller DC, English DR, Jenkins MA, Abramson MJ et al (2010) Asthma, asthma medications, and prostate cancer risk. Cancer Epidemiol Biomark Prev 19(9):2318–2324CrossRef

Platz EA, Drake CG, Wilson KM, Sutcliffe S, Kenfield SA, Mucci LA et al (2015) Asthma and risk of lethal prostate cancer in the Health Professionals Follow-Up Study. Int J Cancer 137(4):949–958CrossRefPubMedPubMedCentral

Daniels-Wells TR, Helguera G, Leuchter RK, Quintero R, Kozman M, Rodriguez JA et al (2013) A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy. BMC Cancer 13:195CrossRefPubMedPubMedCentral

10.

Platzer B, Elpek KG, Cremasco V, Baker K, Stout MM, Schultz C et al (2015) IgE/FcεRI-mediated antigen cross-presentation by dendritic cells enhances anti-tumor immune responses. Cell Rep. doi:10.1016/j.celrep.2015.02.015 PubMedPubMedCentral

11.

Kailaanmaki A, Kinnunen T, Ronka A, Rytkonen-Nissinen M, Lidholm J, Mattsson L et al (2016) Human memory CD4+ T cell response to the major dog allergen Can f 5, prostatic kallikrein. Clin Exp Allergy 46(5):720–729CrossRefPubMed

12.

Centers for Disease Control and Prevention (2016) National Health And Nutrition Examination Survey, 2005–2006. http://wwwn.cdc.gov/Nchs/Nhanes/Search/Nhanes05_06.aspx. Accessed 21 Sept 2016

13.

Salo PM, Calatroni A, Gergen PJ, Hoppin JA, Sever ML, Jaramillo R et al (2011) Allergy-related outcomes in relation to serum IgE: results from the National Health and Nutrition Examination Survey 2005–2006. J Allergy Clin Immunol. 127(5):1226–1235CrossRefPubMedPubMedCentral

14.

Welch HG, Schwartz LM, Woloshin S (2005) Prostate-specific antigen levels in the United States: implications of various definitions for abnormal. J Natl Cancer Inst 97(15):1132–1137CrossRefPubMed

15.

Han YY, Song JY, Talbott EO (2013) Serum folate and prostate-specific antigen in the United States. Cancer Causes Control 24(8):1595–1604CrossRefPubMed

16.

Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V et al (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59(1):61–71CrossRefPubMed

17.

Perzanowski MS, Ronmark E, James HR, Hedman L, Schuyler AJ, Bjerg A et al (2016) Relevance of specific IgE antibody titer to the prevalence, severity, and persistence of asthma among 19-year-olds in northern Sweden. J Allergy Clin Immunol 138(6):1582–1590CrossRefPubMed

18.

Saarelainen S, Taivainen A, Rytkonen-Nissinen M, Auriola S, Immonen A, Mantyjarvi R et al (2004) Assessment of recombinant dog allergens Can f 1 and Can f 2 for the diagnosis of dog allergy. Clin Exp Allergy 34(10):1576–1582CrossRefPubMed

19.

Mattsson L, Lundgren T, Olsson P, Sundberg M, Lidholm J (2010) Molecular and immunological characterization of Can f 4: a dog dander allergen cross-reactive with a 23 kDa odorant-binding protein in cow dander. Clin Exp Allergy 40(8):1276–1287CrossRefPubMed

20.

Cabanas R, Lopez-Serrano MC, Carreira J, Ventas P, Polo F, Caballero MT et al (2000) Importance of albumin in cross-reactivity among cat, dog and horse allergens. J Investig Allergol Clin Immunol 10(2):71–77PubMed

21.

Mattsson L, Lundgren T, Everberg H, Larsson H, Lidholm J (2009) Prostatic kallikrein: a new major dog allergen. J Allergy Clin Immunol 123(2):362–368CrossRefPubMed

22.

Basagana M, Bartolome B, Pastor-Vargas C, Mattsson L, Lidholm J, Labrador-Horrillo M (2012) Involvement of Can f 5 in a case of human seminal plasma allergy. Int Arch Allergy Immunol 159(2):143–146CrossRefPubMed

23.

Nordlund B, Konradsen JR, Kull I, Borres MP, Onell A, Hedlin G et al (2012) IgE antibodies to animal-derived lipocalin, kallikrein and secretoglobin are markers of bronchial inflammation in severe childhood asthma. Allergy 67(5):661–669CrossRefPubMed

24.

Savilahti EM, Rantanen V, Lin JS, Karinen S, Saarinen KM, Goldis M et al (2010) Early recovery from cow’s milk allergy is associated with decreasing IgE and increasing IgG4 binding to cow’s milk epitopes. J Allergy Clin Immunol 125(6):1315–1321CrossRefPubMedPubMedCentral

25.

Savilahti EM, Saarinen KM, Savilahti E (2010) Duration of clinical reactivity in cow’s milk allergy is associated with levels of specific immunoglobulin G4 and immunoglobulin A antibodies to beta-lactoglobulin. Clin Exp Allergy 40(2):251–256CrossRefPubMed

26.

Karagiannis SN, Karagiannis P, Josephs DH, Saul L, Gilbert AE, Upton N, Gould HJ (2013) Immunoglobulin E and allergy: antibodies in immune inflammation and treatment. Microbiol Spectr 1(1)

27.

Karagiannis P, Villanova F, Josephs DH, Correa I, Van Hemelrijck M, Hobbs C et al (2015) Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma. Oncoimmunology 4(11):e1032492CrossRefPubMedPubMedCentral

28.

Josephs DH, Spicer JF, Corrigan CJ, Gould HJ, Karagiannis SN (2013) Epidemiological associations of allergy, IgE and cancer. Clin Exp Allergy 43(10):1110–1123PubMed

29.

Josephs DH, Bax HJ, Dodev T, Georgouli M, Nakamura M, Pellizzari G et al (2017) Anti-folate receptor- α IgE but not IgG recruits macrophages to attack tumors via TNF-α/MCP-1 signaling. Cancer Res 77:1127–1141CrossRefPubMed

Title: Atopy and prostate cancer: Is there a link between circulating levels of IgE and PSA in humans?
Authors: Mieke Van Hemelrijck
Sophia N. Karagiannis
Sabine Rohrmann
Publication date: 01-12-2017
Publisher: Springer Berlin Heidelberg
Published in: Cancer Immunology, Immunotherapy / Issue 12/2017
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI: https://doi.org/10.1007/s00262-017-2048-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 12/2017

Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11)

Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment

Clinical evaluation of macrophages in cancer: role in treatment, modulation and challenges

An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejection

Evaluation of a xenogeneic vascular endothelial growth factor-2 vaccine in two preclinical metastatic tumor models in mice

CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer